Philips Installs State-of-the-Art Hybrid Operating Room at Leading Russian Medical Institute in Moscow

Royal Philips ElectronicsThe Russian Cardiology Research and Production Complex and Royal Philips (NYSE: PHG, AEX: PHIA) today announced the opening of an innovative new hybrid operating room equipped with advanced live image guidance solutions to guide minimally-invasive cardiovascular and endovascular procedures. This new hybrid operating room, which also features other Philips technology innovations, is the first of its kind in Russia.

As surgical procedures continue to evolve from open surgery to minimally-invasive procedures, surgeons require a single hybrid operating room solution that meets the needs of both types of surgery. The new hybrid operating room at the Federal Russian Cardiology Research and Production Complex is equipped with Philips' latest interventional tools, such as its Allura Xper FD20 system with FlexMove for easy access to high resolution imaging and its HeartNavigator navigation tool, to support a wide range of minimally-invasive procedures. These include the repair of restrictions (stenoses) or ballooning (aneurysms) in arteries or veins, and minimally-invasive heart valve replacement (Transcatheter Aortic Valve Implantation (TAVI)).

"A hybrid intervention in cardiac surgery is associated with minimal patient trauma and gives positive results in 95% to 97% of the procedures," says Renat S. Akchurin, academician, associate professor of cardiovascular surgery and honorary Member of the Russian Academy of Sciences and Medical Sciences (RAS & RAMS). "The results are really impressive. Patients recover quickly and leave the hospital after a relatively short period of time."

The Russian Cardiology Research and Production Complex is a federal institute and is Russia's leading national clinical and research institute for applied and fundamental cardiology. It leads the coordination of Russia's national research programs in the field of cardiovascular diseases.

After the opening ceremony for the new hybrid operating room, Renat S. Akchurin and Karl E. Hauptmann MD, Chief of the Cardiology Division at the Hospital of Barmherzigen BrĂ¼der (Trier, Germany), are performing TAVI and EVAR (Endovascular Aneurysm Repair) procedures that will be webcast live in both the Russian and English languages via www.philips.ru/live. The webcast starts at 08:20 AM CET.

Participants will have the opportunity to ask questions and listen to answers online during the procedure. This will allow healthcare professionals and laypeople worldwide to learn more about new methods of treatment and new technologies for imaging and cardiac surgery.

"Philips is dedicated to creating the future of healthcare by delivering innovative solutions that address major healthcare challenges, such as the rise of cardiovascular disease," says Arjan de Jongste, Market Leader Philips Russia and Central Asia. "Because of the benefits to patients and care providers of image-guided minimally invasive treatments, such as greater patient comfort, shorter recovery periods, and faster patient throughput, it is a fast growing field of medicine and a key area of innovation for Philips."

Philips equipment installed in the hybrid operating room at this renowned Russian cardiology center also simplifies the workflow. Philips has installed its ceiling-mounted FlexMove option, allowing the Allura Xper FD 20 interventional X-ray imaging system to be moved both laterally and longitudinally in order to guarantee optimal access to the patient throughout procedures. Moreover, live 3D image guidance tools provide extra support for TAVI procedures: Philips HeartNavigator is an innovative procedure planning and image guidance tool to help interventional cardiologists and cardiac surgeons perform such procedures. The tool merges pre-operatively acquired 3D CT scans of the patient's heart with the live interventional X-ray views. Using this technology, physicians can now simultaneously see the detailed 3D anatomy of the patient's heart together with the positioning of the catheter and the placement and deployment of the artificial valve.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 115,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...